首页> 美国政府科技报告 >Targeting of the Nuclear Receptor Co-activator Isoform delta 3A1B in Breast Cancer
【24h】

Targeting of the Nuclear Receptor Co-activator Isoform delta 3A1B in Breast Cancer

机译:在乳腺癌中靶向核受体共激活因子异构体δ3a1B

获取原文

摘要

AIB1 which stands for Amplified in Breast cancer, codes for a protein that is a member of the steroid receptor coactivator (SRC) family. AIB1 is amplified in approximately 5-10% of breast cancers and the mRNA and protein over expressed in >30% of breast cancers. AIB1 interacts with a super family of ligand activated nuclear receptors to potentiate transcriptional activity leading to upregulation of downstream target gene expression. An important finding was that an isoform of AIB1 (delta3AIB1) is a significantly more effective coactivator of the estrogen receptor than AIB1 and is highly over expressed in human breast cancer. Prior work in our lab showed that the downregulation of overall levels of AIB1 plus delta3AIB1, using a regulatable AIB1 directed ribozyme, resulted in reduced tumor growth in vivo. Overall, these data indicate a major role for AIB1 and its isoform delta3AIB1 in breast cancer development and growth. However the relative roles of AIB1 versus the more highly active delta3AIB1 in phenotypic changes in the breast has not been determined. In this investigation, we are developing a method to use siRNA directed at delta3AIB1 in order investigate its role in breast cancer and as a possible future therapeutic approach to breast cancer.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号